Fig 1: Expression of hsa‐miR‐5001‐5p, hsa‐miR‐203a and hsa‐miR‐210‐3p is regulated by androgen and alterations of these miRNAs regulate migration and invasion of PCa cells. (A) The miRNA array was used to examine the effect of androgen treatment on expression of miRNAs in PC‐3 and PC‐3AR cells being treated with or without 10 nM dihydrotestosterone (DHT) for 48 h. The expression level of miRNAs was demonstrated using log2 value. (B) Effect of androgen treatment on expression of hsa‐miR‐5001‐5p, hsa‐miR‐26a‐5p, hsa‐miR‐203a, hsa‐miR‐210‐3p, hsa‐509‐3, and hsa‐miR‐532‐3p in PC‐3 and PC‐3AR cells with or without 10 nM DHT for 48 h was examined by qRT‐PCR. (C) Protein expression of E‐cadherin, N‐cadherin, AR, and YAP in PC‐3AR cells being treated with 10 nM DHT (C) or with or without 10 nM DHT (D) as well as inhibitor targeting hsa‐miR‐203a or hsa‐miR‐210‐3p, or overexpression plasmid for hsa‐miR‐5001‐5p for 48 h was assayed. The expression of hsa‐miR‐203a and hsa‐miR‐210‐3p (E), the migration (F), and invasion (G) in PC‐3AR cells being treated with or without inhibitor was examined by qRT‐PCR and transwell assay, respectively. The expression of hsa‐miR‐5001‐5p (H), the migration and invasion (I) in PC‐3AR cells being transfected with or without overexpression plasmid of hsa‐miR‐5001‐5p in the presence of absence of 10 nM DHT for 24 h was examined by qRT‐PCR and transwell assay, respectively (J) Binding of AR with promoter of miR210‐3p in PC‐3AR cells being treated with 0 or 10 nM DHT as determined by chromatin immunoprecipitation (ChIP) assay. *, **, *** represent statistically significant difference p < 0.05, p < 0.01, p < 0.001 respectively.
Supplier Page from OriGene Technologies for MIR5001 Human MicroRNA Expression Plasmid (MI0017867)